Clin2
NCT07838740Possibly a fitRecruiting

Weekly weight-loss medication for healthy adults with obesity

Obese Adults

Part of Hormones & metabolism clinical trials.

This early-stage trial tests a new once-weekly medication (VK2735) that may help with weight loss. It's for healthy adults with obesity who do not have other significant health problems like diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
270 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must have a BMI of 30 or higher (this means you have obesity).
  • You need to be generally healthy with no major medical conditions.
  • You cannot have diabetes (type 1 or type 2) or a history of it.
  • You must not have a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or a genetic condition called MEN-2.
  • Your liver and kidney function must be within normal limits (checked by blood tests).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07846033Recruiting· Phase 1
Study of the experimental drug VK3019 for adults with overweight or obesity

This early-phase study tests an experimental medicine called VK3019 in adults who are overweight or have obesity but are otherwise healthy. The goal is to see if the drug is safe and how the body handles it, which may lead to future weight-management options.

Lake Forest, California
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07868835Not yet recruiting· Phase 3
Oral weight management pill for adults with obesity

This study tests an oral medication (VK2735) that may help adults with obesity or overweight with weight-related health issues lose weight. Participants take the pill as part of the trial to see if it is safe and effective for weight management.

NCT07628127Recruiting· Phase 1
Weight loss pill study for adults with excess weight

This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.

Brisbane
NCT07192263Not yet recruiting· Phase 3
Weight loss injection for adults with obesity or overweight

This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.

NCT07809945Not yet recruiting· Phase 1
Weight loss study for people with overweight or obesity

This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.

Beijing, Beijing Municipality

Hear when a new Obese Adults trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.